Disturbing reason why drugs like Ozempic come with the most serious type of warning attached as experts explain risks
ArchiveFirst published May 28, 2025. It may not reflect later developments.
Ozempic and other GLP-1 drugs like Mounjaro and Wegovy are making headlines for their weight loss benefits. Originally designed to treat type 2 diabetes, they’ve surged in popularity—especially among celebrities—for their appetite-suppressing effects.
But what many don’t know is that these medications carry the FDA’s most serious warning: a boxed warning. This label highlights potentially life-threatening risks, including a concerning link to thyroid tumors. Animal studies showed a connection to thyroid cancer, prompting the warning. The FDA advises against taking these drugs if you have a personal or family history of such cancers.
Still, new research from 2024 offers some reassurance. It found no strong evidence of increased thyroid cancer risk in humans taking GLP-1 drugs, though it didn’t entirely rule out a small risk.
Experts urge caution. Dr. Kristopher Day emphasized that newer studies benefit from better tools and longer follow-up. However, before using drugs like Ozempic, it’s crucial to talk with your doctor.
These medications can be effective, but they’re not risk-free—so stay informed before starting.
